Uptravi (selexipag), an approved oral therapy for adults with pulmonary arterial hypertension (PAH), appears to…
Vanessa Pataia
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Vanessa Pataia
Tenax Therapeutics has completed its Phase 2 HELPÂ clinical trial testing levosimendan…
The biopharmaceutical PhaseBio announced positive results from a case study involving a patient…